This early-phase study tests whether a single infusion of special immune cells (regulatory dendritic cells) from the kidney donor can help the recipient's body accept the new kidney with fewer side effects. 14 first-time kidney transplant recipients will receive the cells one wee…
Phase: PHASE1 • Sponsor: Angus W. Thomson PhD DSc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC